Literature DB >> 27884549

Time before anti-Toxoplasma IgG seroconversion detection by 7 commercial assays in French pregnant women.

Catherine Armengol1, Sophie Cassaing2, Christine Roques-Malecaze1, Pamela Chauvin1, Xavier Iriart1, Antoine Berry1, Judith Fillaux3.   

Abstract

We assessed the ability to early detect a toxoplasmic seroconversion between 1 immunoblot (LDBIO II®) and 6 automated assays (TGS TA®, Architect®, Vidas II®, Liaison II®, Platelia®, and Elecsys®), comparing the time before anti-Toxoplasma gondii IgG detection during infection in pregnant women. From 2007 to 2015, 620 sera of 269 women were included. The median durations before positive IgG detection with Vidas II®, Liaison II®, Platelia®, and Elecsys® were significantly longer than Architect® with differential times from 11 to 28days (P<0.001). This time was significantly shortened by the use of LDBIO®, resulting in a saving of 13days (P<0.001). The detection of a positive rate of IgG with TGS TA® was as early as Architect® (P=0.105). The ability to early detect a toxoplasmic seroconversion is not equivalent between the assays and has to be considered when selecting the reagents to reduce the time to therapeutic intervention.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Automated tests; Immunoblot; Immunodiagnosis; Pregnancy; Seroconversion; Toxoplasma gondii

Mesh:

Substances:

Year:  2016        PMID: 27884549     DOI: 10.1016/j.diagmicrobio.2016.10.020

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  5 in total

1.  Diagnosis of Congenital Toxoplasmosis: Performance of Four IgG and IgM Automated Assays at Birth in a Tricentric Evaluation.

Authors:  Marine Avignon; Maude F Lévêque; Emilie Guemas; Milène Sasso; Sahar Albaba; Laurence Lachaud; Judith Fillaux
Journal:  J Clin Microbiol       Date:  2022-05-02       Impact factor: 11.677

Review 2.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

3.  Performance of seven commercial automated assays for the detection of low levels of anti-Toxoplasma IgG in French immunocompromised patients.

Authors:  Tiphaine Douet; Catherine Armengol; Elena Charpentier; Pamela Chauvin; Sophie Cassaing; Xavier Iriart; Antoine Berry; Judith Fillaux
Journal:  Parasite       Date:  2019-08-23       Impact factor: 3.000

4.  Anti-Toxoplasma IgG assays: What performances for what purpose? A systematic review.

Authors:  Florence Robert-Gangneux; Hélène Guegan
Journal:  Parasite       Date:  2021-04-26       Impact factor: 3.000

5.  Diagnostic Accuracy of LDBIO-Toxo II IgG and IgM Western Blot in Suspected Seroconversion in Pregnancy: A Multicentre Study.

Authors:  Valeria Meroni; Francesca Genco; Luigia Scudeller; Marie-Pierre Brenier-Pinchart; Hélène Fricker-Hidalgo; Coralie L'Ollivier; Luc Paris; Hervé Pelloux
Journal:  Pathogens       Date:  2022-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.